SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950142-22-001796
Filing Date
2022-06-01
Accepted
2022-06-01 07:38:25
Documents
14
Period of Report
2022-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K eh220257384_8k.htm   iXBRL 8-K 42292
2 EXHIBIT 1.1 eh220257384_ex0101.htm EX-1.1 280220
3 EXHIBIT 99.1 eh220257384_ex9901.htm EX-99.1 14060
  Complete submission text file 0000950142-22-001796.txt   585952

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vtvt-20220531.xsd EX-101.SCH 2980
5 XBRL LABEL FILE vtvt-20220531_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vtvt-20220531_pre.xml EX-101.PRE 22373
8 EXTRACTED XBRL INSTANCE DOCUMENT eh220257384_8k_htm.xml XML 3610
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 22985982
SIC: 2834 Pharmaceutical Preparations